FDA Discontinues Advisory Committee Meeting for Biohaven Treatment; Catalent Announces Staff Reductions

FDA Discontinues Advisory Committee Meeting for Biohaven Treatment; Catalent Announces Staff Reductions

FDA Discontinues Advisory Committee Meeting for Biohaven Treatment; Catalent Announces Staff Reductions